The Science Behind Tirzepatide Tirzepatide is designed to mimic the effects of two gut hormones: Glucagon-like peptide-1 (GLP-1) Glucose-dependent insulinotropic polypeptide (GIP) Both are classified as incretins, hormones that stimulate insulin secretion in response to meals
Superguts products help to diversify the prebiotic fibre content youre ingesting and marry complementary elements like resistant starches and beta-glucan
Not intended for direct injection without an active drug
The speed and magnitude of response to GLP-1 therapy varies significantly between individuals due to multiple physiological and practical factors
Patients in clinical trials, such as Sustain 7 and Step 1, secured impressive results, ranging from over 14 pounds lost on average in 40 weeks with a stand-alone GLP-1 program to up to 44 pounds in 68 weeks with GLP-1 combined with diet and exercise
In these linagliptin studies, no overall differences in safety or effectiveness of linagliptin were observed between geriatric patients and younger adult patients
